Skip to content

Protein ECT2 (ECT2)

Homo sapiens — UniProt Q9H8V3

Gene: ECT2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Protein ECT2 (ECT2) is a protein from Homo sapiens identified by UniProt accession Q9H8V3, 914 residues long. MolForge cross-references it against 0 known binders and 188 disease associations.

  • UniProt accession: Q9H8V3; gene symbol ECT2.
  • Organism: Homo sapiens.
  • Length: 914 amino acids.
  • Top disease associations (Open Targets): platelet count, neurodegenerative disease and TNF-related apoptosis-inducing ligand measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameProtein ECT2
UniProt accessionQ9H8V3
GeneECT2
OrganismHomo sapiens
Length914 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (188)

Diseases linked to this target (Open Targets).

  • platelet count · score 0.44
  • neurodegenerative disease · score 0.32
  • TNF-related apoptosis-inducing ligand measurement · score 0.24
  • breast adenocarcinoma · score 0.18
  • clavicle fracture · score 0.16
  • platelet crit · score 0.13
  • glioblastoma multiforme · score 0.12
  • neoplasm · score 0.11
  • lung adenocarcinoma · score 0.10
  • non-small cell lung carcinoma · score 0.10

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9H8V3-F1alphafoldPREDICTED70.44—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9H8V3.

Amino-acid sequence (914 residues)

MAENSVLTST TGRTSLADSS IFDSKVTEIS KENLLIGSTS YVEEEMPQIE TRVILVQEAG KQEELIKALK TIKIMEVPVI KIKESCPGKS DEKLIKSVIN MDIKVGFVKM ESVEEFEGLD SPEFENVFVV TDFQDSVFND LYKADCRVIG PPVVLNCSQK GEPLPFSCRP LYCTSMMNLV LCFTGFRKKE ELVRLVTLVH HMGGVIRKDF NSKVTHLVAN CTQGEKFRVA VSLGTPIMKP EWIYKAWERR NEQDFYAAVD DFRNEFKVPP FQDCILSFLG FSDEEKTNME EMTEMQGGKY LPLGDERCTH LVVEENIVKD LPFEPSKKLY VVKQEWFWGS IQMDARAGET MYLYEKANTP ELKKSVSMLS LNTPNSNRKR RRLKETLAQL SRETDVSPFP PRKRPSAEHS LSIGSLLDIS NTPESSINYG DTPKSCTKSS KSSTPVPSKQ SARWQVAKEL YQTESNYVNI LATIIQLFQV PLEEEGQRGG PILAPEEIKT IFGSIPDIFD VHTKIKDDLE DLIVNWDESK SIGDIFLKYS KDLVKTYPPF VNFFEMSKET IIKCEKQKPR FHAFLKINQA KPECGRQSLV ELLIRPVQRL PSVALLLNDL KKHTADENPD KSTLEKAIGS LKEVMTHINE DKRKTEAQKQ IFDVVYEVDG CPANLLSSHR SLVQRVETIS LGEHPCDRGE QVTLFLFNDC LEIARKRHKV IGTFRSPHGQ TRPPASLKHI HLMPLSQIKK VLDIRETEDC HNAFALLVRP PTEQANVLLS FQMTSDELPK ENWLKMLCRH VANTICKADA ENLIYTADPE SFEVNTKDMD STLSRASRAI KKTSKKVTRA FSFSKTPKRA LRRALMTSHG SVEGRSPSSN DKHVMSRLSS TSSLAGIPSP SLVSLPSFFE RRSHTLSRST THLI

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with ECT2?

The strongest Open Targets associations for ECT2 are platelet count, neurodegenerative disease, TNF-related apoptosis-inducing ligand measurement, breast adenocarcinoma and clavicle fracture.

How long is the ECT2 protein?

The Homo sapiens ECT2 protein (UniProt Q9H8V3) is 914 amino acids long.

Browse: Targets: E · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Protein ECT2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9H8V3
GeneECT2
OrganismHomo sapiens
Length914
Binders0
Diseases188
View on UniProt